Literature DB >> 25902902

A novel cardioprotective mechanism of exogenous nitric oxide: inhibition of Rho-associated kinase activity.

Atsushi Tanaka1, Koichi Node1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25902902     DOI： 10.1038/hr.2015.61

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


× No keyword cloud information.
  13 in total

1.  Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling.

Authors:  Kanchan Chitaley; R Clinton Webb
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

Review 2.  Rocks: multifunctional kinases in cell behaviour.

Authors:  Kirsi Riento; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

Review 3.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

4.  Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial.

Authors:  Tatsuya Maruhashi; Kensuke Noma; Noritaka Fujimura; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Ayumu Nakashima; Yasuki Kihara; James K Liao; Yukihito Higashi
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

5.  Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.

Authors:  V Sauzeau; H Le Jeune; C Cario-Toumaniantz; A Smolenski; S M Lohmann; J Bertoglio; P Chardin; P Pacaud; G Loirand
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment.

Authors:  Yoku Kikuchi; Satoshi Yasuda; Kentaro Aizawa; Ryuji Tsuburaya; Yoshitaka Ito; Morihiko Takeda; Masaharu Nakayama; Kenta Ito; Jun Takahashi; Hiroaki Shimokawa
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

7.  Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

Authors:  K Kimura; M Ito; M Amano; K Chihara; Y Fukata; M Nakafuku; B Yamamori; J Feng; T Nakano; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-07-12       Impact factor: 47.728

8.  Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.

Authors:  Masahiro Mohri; Hiroaki Shimokawa; Yoji Hirakawa; Akihiro Masumoto; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.

Authors:  Xia Cao; Tao Luo; Xi Luo; Zhiyi Tang
Journal:  Hypertens Res       Date:  2014-06-26       Impact factor: 3.872

10.  Critical role of exogenous nitric oxide in ROCK activity in vascular smooth muscle cells.

Authors:  Tatsuya Maruhashi; Kensuke Noma; Yumiko Iwamoto; Akimichi Iwamoto; Nozomu Oda; Masato Kajikawa; Takeshi Matsumoto; Takayuki Hidaka; Yasuki Kihara; Kazuaki Chayama; Ayumu Nakashima; Chikara Goto; James K Liao; Yukihito Higashi
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240
View more
  1 in total

1.  Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway.

Authors:  Wared Nour-Eldine; Crystal M Ghantous; Kazem Zibara; Leila Dib; Hawraa Issaa; Hana A Itani; Nabil El-Zein; Asad Zeidan
Journal:  Front Pharmacol       Date:  2016-04-07       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.